Microglandular adenocarcinoma of the uterus mimicking microglandular cervical hyperplasia

Annals of Diagnostic Pathology

Volumn 7, Issue 3, 2003, Pages 180-186

  Zamecnik, Michal ^a   Skalova, Alena ^b   Opatrny, Vaclav ^b  

^a BIOPTICAL LABORATORY   (Czech Republic)

^b NONE

Author keywords

Endometrioid adenocarcinoma; Microglandular adenocarcinoma; Microglandular hyperplasia; Uterus; Vimentin

Indexed keywords

VIMENTIN;

AGED; ARTICLE; CASE REPORT; CELL PROLIFERATION; CURETTAGE; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; INVASIVE CARCINOMA; MICROGLANDULAR CERVICAL HYPERPLASIA; MYOMETRIUM; NEUTROPHIL; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; UTERINE CERVIX; UTERINE CERVIX DISEASE;

EID: 0037790867     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1092-9134(03)00018-2     Document Type: Article

References (34)

1. Nichols TM, Fidler HK: Microglandular hyperplasia in cervical cone biopsies taken for suspicious and positive cytology. Am J Clin Pathol 1971;56:424-429
2. Damjanov I: Microglandular hyperplasia of endocervical glands as a consequence of the use of oral contraceptives. Lijec Vjesn 1970;92:1049-1054
3. Young RH, Scully RE: Uterine carcinomas simulating microglandular hyperplasia. A report of six cases. Am J Surg Pathol 1992;16:1092-1097
4. Fukunaga M: Mucinous endometrial adenocarcinoma simulating microglandular hyperplasia of the cervix. Pathol Int 2000;50:541-545
5. McCluggage WG, Perenyei M: Microglandular adenocarcinoma of the endometrium. Histopathology 2000;37:285-287
6. Zaloudek C, Hayashi GM, Ryan IP, et al: Microglandular adenocarcinoma of the endometrium: A form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix. Int J Gynecol Pathol 1997;16:52-59
7. Young RH, Scully RE: Atypical forms of microglandular hyperplasia of the cervix simulating carcinoma. A report of five cases and review of the literature. Am J Surg Pathol 1989;13:50-56
8. Young RH, Clement PB: Pseudoneoplastic glandular lesions of the uterine cervix. Semin Diagn Pathol 1991;8:234-249
9. Dabbs DJ, Geisinger KR, Norris HAT: Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol 1986;10:568-576
10. Dabbs DJ, Sturtz K, Zaino RJ: The immunohistochemical discrimination of endometrioid adenocarcinomas. Hum Pathol 1996;27:172-177
11. Jinnouchi H: An immunohistochemical study of difference between cervical and endometrial adenocarcinomas of the uterus-Using monoclonal antibodies of vimentin and cytokeratin. Fukushima J Med Sci 1987;33:85-108
12. Marques T, Andrade LA, Vassallo J: Endocervical tubal metaplasia and adenocarcinoma in situ: Role of immunohistochemistry for carcinoembryonic antigen and vimentin in differential diagnosis. Histopathology 1996;28:549-550
13. Ohwada M, Suzuki M, Tamada T: Immunohistochemical investigation of vimentin of uterine endometrial and endocervical adenocarcinoma. Nippon Sanka Fujinka Gakkai Zasshi 1990;42:1237-1243
14. Tamimi HK, Gown AM, Kim-Deobald J, et al: The utility of immunocytochemistry in invasive adenocarcinoma of the cervix. Am J Obstet Gynecol 1992;16:1655-1662
15. Yuasa T: Immunohistochemical study of cytokeratin and vimentin expression in mixed type of adenocarcinoma and squamous cell carcinoma. Nippon Sanka Fujinka Gakkai Zasshi 1996;48:867-874
16. Lang G, Dallenbach-Hellweg G: The histogenetic origin of cervical mesonephric hyperplasia and mesonephric adenocarcinoma of the uterine cervix studied with immunohistochemical methods. Int J Gynecol Pathol 1990;9:145-157
17. Samaratunga H, Beresford A, Davison A: Squamous cell carcinoma in situ involving mesonephric remnants. A potential diagnostic pitfall. Am J Surg Pathol 1994;18:1265-1269
18. Silver SA, Devouassoux-Shisheboran M, Mezzetti TP, et al: Mesonephric adenocarcinomas of the uterine cervix: A study of 11 cases with immunohistochemical findings. Am J Surg Pathol 2001;25:379-387
19. Stewart CJ, Taggart CR, Brett F, et al: Mesonephric adenocarcinoma of the uterine cervix with focal endocrine cell differentiation. Int J Gynecol Pathol 1993;12:264-269
20. Zamecnik M: Atypical oxyphilic metaplasia of the uterine cervix. Report of a case. Cesko-Slovenska Patologie 2000;36:60-64
21. Cina SJ, Richardson MS, Austin RM, et al: Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol 1997;10:176-180
22. Cohen C, Shulman G, Budgeon LR: Endocervical and endometrial adenocarcinoma: An immunoperoxidase and histochemical study. Am J Surg Pathol 1982;6:151-157
23. McCluggage WG, Sumathi VP, McBride HA, et al: A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol 2002;21:11-15
24. Nanbu Y, Fujii S, Konishi I, et al: Immunohistochemical localizations of CA 195, carcinoembryonic antigen, and CA 19-9 in normal and neoplastic glandular cells of the uterine cervix. Cancer 1988;62:2580-2588
25. Speers WC, Picaso LG, Silverberg SG: Immunohistochemical localization of carcinoembryonic antigen in microglandular hyperplasia and adenocarcinoma of the endocervix. Am J Clin Pathol 1983;79:105-107
26. Steeper TA, Wick MR: Minimal deviation adenocarcinoma of the uterine cervix ("adenoma malignum"). An immunohistochemlcal comparison with microglandular endocervical hyperplasia and conventional endocervical adenocarcinoma. Cancer 1986;58:1131-1138
27. Suzuki M, Ohwada M, Tamada T, et al: Immunohistochemical study of carcinoembryonic antigen of the tissue and cell levels in adenocarcinoma of the uterus. Nippon Sanka Fujinka Gakkai Zasshi 1985;37:897-902
28. Toki T, Oikawa N, Tase T, et al: Immunohistochemical localization of carcinoembryonic antigen in adenocarcinoma of the endocervix and the endometrium. Tohoku J Exp Med 1985;146:27-32
29. Ueda S, Tsubura A, Izumi H, et al: Immunohistochemical studies on carcinoembryonic antigen in adenocarcinomas of the uterus. Acta Pathol Jpn 1983;33:59-69
30. Wahlstrom T, Lindgren J, Korhonen M, et al: Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histological tissue specimens. Lancet 1979;2:1159-1160
31. Lax SF, Pizer ES, Ronnett BM, et al: Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation. Hum Pathol 1998;29:924-931
32. Halperin R, Zehavi S, Habler L, et al: Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium. Eur J Gynaecol Oncol 2001;22:122-126
33. Koshiyama M, Konishi I, Wang DP, et al: Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: Inverse correlation with sex steroid receptor status. Virchows Arch A Pathol Anat Histopathol 1993;423:265-271
34. Jacques SM, Qureshi F, Lawrence WD: Surface epithelial changes in endometrial adenocarcinoma: Diagnostic pitfalls in curettage specimens. Int J Gynecol Pathol 1995;14:191-197